Methyl 1,2,3,4-tetrahydroisoquinoline-8-carboxylate hydrochloride, 95.0%, 1g

3-Methoxy-2,5-dimethylpyrazine, 95.0%, 250mg

Allyltriphenylphosphonium bromide, 95.0%, 500g

N,N-dimetilanilina, >=99%, para síntesis, 2,5 L, envase de vidrio

Matraces aforados clase B transparente, 500 ml, 19/26, 2 Pieza(s)

C-(3-Methoxy-phenyl)-C-phenyl-methylamine, 95.0%, 1g

D-Tyrosine, O-(1,1-dimethylethyl)-N-[(phenylmethoxy)carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1) (9CI), 98%, 10g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hept-6-enoic acid, 98%, 500mg

Matraces de dos bocas en forma de pera, 100 ml, 14/23, 1 Pieza

2-Chloro-1-{1h,2h,3h,4h,5h-pyrido[4,3-b]indol-2-yl}ethan-1-one, 95%, 1g

8-benzyl-7,8-dihydrotetrazolo[1,5-a]pyrazin-6(5H)-one, 250mg

1-Methyl-2-(trifluoromethyl)-1H-benzo[d]imidazole, 98%, 250mg

Triphenylpropylphosphonium Bromide>98.0%(HPLC)(T)500g